Aster DM Healthcare financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹1,311cr+21.6% on Q1 FY26
Net profit
₹29.3cr−68.7% on Q1 FY26
EBITDA margin
20.2%+0.9 pts on Q1 FY26
EPS
₹0.31−81.4% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue1,3111,078+21.6%
EBITDA264207+27.5%
EBITDA margin20.2%19.2%+0.9 pts
Profit before tax86.5142−39.2%
Net profit29.393.6−68.7%
EPS₹0.31₹1.67−81.4%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹1,311 crNet profit₹29.3 crNet margin2.2%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
34,686————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
22922916685.5390
258258223470412
7017016426692,287
35,416————
4,8764,6434,1383,69911,933
—+12.2%+11.9%−69.0%—
9589017655781,565
19.6%19.4%18.5%15.6%13.1%
688637516358785
3634275,408212475
7.4%9.2%130.7%5.7%4.0%
₹6.15₹7.49₹103.79₹2.50₹8.20
—−92.8%+4,059.8%−69.6%—
—6564251581,834
—−478−357−806−848
17817868.3−648986
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ASTERDM₹669.45

Aster DM Healthcare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHKIMSCOHANCEWOCKPHARMASYNGENEGLANDLALPATHLABMcap ₹34,686 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————34,686.2
- Cash, Equiv & ST Investments389.885.5166.0229.5229.5
+ Minority Interest412.4470.3223.4257.8257.8
+ Total Debt2,287.5669.3642.2701.2701.2
Enterprise Value————35,415.8
Revenue11,932.93,698.94,138.54,643.24,876.0
Growth %, YoY—-69.0+11.9+12.2—
EBITDA1,565.3578.0764.5901.0958.0
Margin %13.1215.6218.4719.4119.65
EBIT784.8358.0515.7636.8687.7
Net Income475.5211.65,407.9427.1362.8
Margin %3.985.72130.679.207.44
EPS, Adj (current shares)8.202.50103.797.496.15
Growth %, YoY—-69.6+4,059.8-92.8—
Cash from Operations1,834.0157.8425.1655.9—
Capital Expenditures-848.2-805.6-356.7-477.5—
Free Cash Flow985.8-647.868.3178.4178.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Aster DM Healthcare financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Aster DM Healthcare (NSE: ASTERDM) had a market capitalisation of ₹35,191 crore at the 29 October 2026 close (₹679.20 a share), a PE ratio of 110.4 on the last four quarters' profit and a price-to-book ratio of 7.69. In FY26 its consolidated net profit attributable to shareholders was ₹388 crore on revenue of ₹4,643 crore; in Q1 FY27 (April–June 2026) it was ₹16.1 crore, down 81.2% year on year. Its debt-to-equity ratio was 0.15 on 31 March 2026. Promoters held 53.79% of the shares on 30 September 2026.

Share price used
₹679.20 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Aster DM Healthcare at a glance · consolidated

Market cap
₹35,191 Crat ₹679.20 · 29 Oct close
PE ratio (last 4 quarters)
110.490.7 on FY26 profit
Price to book (PB)
7.69book value ₹88.31 a share
ROE (FY26)
9.7%−125.0 pts vs FY25ROCE 9.9%
Debt to equity
0.15net cash ₹626 Cr
Promoter holding
53.79%+13.4 pts vs 30 Jun 202630 September 2026
Dividend yield
0.44%₹3 a share in 12 months
Net worth
₹4,576 Cr+33.5% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹178 Cr+161.1% vs FY25

Questions

What is the Aster DM Healthcare PE ratio today?

Aster DM Healthcare's PE ratio is 110.4 at the 29 October 2026 close (₹679.20 a share): a market capitalisation of ₹35,191 crore divided by consolidated net profit attributable to shareholders of ₹319 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹388 crore) it is 90.7. These four quarters include net exceptional items of −₹143 crore (one-off charges reported separately), so the ratio on recurring profit would differ.

What is the Aster DM Healthcare PB ratio (price to book value)?

Aster DM Healthcare's price-to-book (PB) ratio is 7.69 at the 29 October 2026 close: a market capitalisation of ₹35,191 crore divided by shareholders' equity (book value) of ₹4,576 crore on 31 March 2026. That is a book value of ₹88.31 per share against a share price of ₹679.20.

What is the Aster DM Healthcare ROE and ROCE?

In FY26, Aster DM Healthcare's return on equity (ROE) was 9.7% and its return on capital employed (ROCE) was 9.9%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 134.7% and ROCE 4.5%.

What is the Aster DM Healthcare market cap?

Aster DM Healthcare's market capitalisation was ₹35,191 crore at the 29 October 2026 close: 51.81 crore shares at ₹679.20 each.

Is Aster DM Healthcare debt free?

No. Aster DM Healthcare had borrowings of ₹701 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.15. Its cash and current investments were ₹1,327 crore, so it held net cash of ₹626 crore.

What is the Aster DM Healthcare EPS?

Aster DM Healthcare's basic earnings per share (EPS) were ₹7.53 in FY26, against ₹107.98 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹6.18.

What is the Aster DM Healthcare debt to equity ratio?

Aster DM Healthcare's debt-to-equity ratio was 0.15 on 31 March 2026: borrowings of ₹701 crore against total equity of ₹4,834 crore. A year earlier, on 31 March 2025, it was 0.18.

What is the Aster DM Healthcare net worth?

Aster DM Healthcare's net worth — shareholders' equity in its consolidated balance sheet — was ₹4,576 crore on 31 March 2026, up 33.5% from ₹3,428 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹35,191 crore at the 29 October 2026 close.

What is the Aster DM Healthcare book value per share?

Aster DM Healthcare's book value per share was ₹88.31 on 31 March 2026: shareholders' equity of ₹4,576 crore divided by the 51.81 crore shares in issue, up 28.7% from ₹68.63 a year earlier. The share price at the 29 October 2026 close was ₹679.20.

What is the Aster DM Healthcare dividend yield?

Aster DM Healthcare's dividend yield is 0.44% at the 29 October 2026 close: dividends of ₹3 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹679.20. They were ₹3 on 2 April 2026 (interim).

What is the Aster DM Healthcare promoter holding?

Promoters held 53.79% of Aster DM Healthcare on 30 September 2026, up 13.40 percentage points from 40.39% the previous quarter and up 13.40 percentage points from 40.39% a year earlier, according to the shareholding pattern filed with NSE.

What is the Aster DM Healthcare free cash flow?

In FY26, Aster DM Healthcare generated ₹656 crore of cash from operations and spent ₹478 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹178 crore. In FY25 it was ₹68.3 crore.

What is the Aster DM Healthcare dividend in 2026 and its record date?

In 2026, Aster DM Healthcare has declared one dividend: ₹3 (interim) with record date 3 April 2026 and ex-date 2 April 2026.

What are the Aster DM Healthcare latest quarterly results?

Aster DM Healthcare's latest results are for Q1 FY27 (April–June 2026), filed on 5 August 2026: consolidated net profit attributable to shareholders ₹16.1 crore, down 81.2% from ₹85.5 crore in Q1 FY26; revenue from operations ₹1,311 crore, up 21.6% year on year.

When are the Aster DM Healthcare next results?

Aster DM Healthcare will announce its Q2 FY27 results (July–September 2026) on Friday, 6 November 2026, the date of the board meeting it has notified to the exchanges.

What is the Aster DM Healthcare shareholding pattern?

On 30 September 2026, Aster DM Healthcare's shares were held by promoters 53.79%, foreign portfolio investors (FII/FPI) 12.26%, domestic institutions (DII) 21.67% (including mutual funds at 20.76%) and retail and other non-institutional investors 12.17%. Over the year, FII holding was down 6.46 percentage points from 18.72% and DII holding was down 4.65 percentage points from 26.32%.

How does the Aster DM Healthcare PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Aster DM Healthcare's PE ratio is 90.7, the second highest of the four: Apollo Hospitals Enterprise 60.7, Max Healthcare Institute 57.4 and Krishna Institute of Medical Sciences 122.2, a peer average of 80.1. Each is the company's market capitalisation at that price divided by its FY26 net profit.

Aster DM Healthcare vs Apollo Hospitals Enterprise: how do they compare?

In FY26, Aster DM Healthcare earned net profit attributable to shareholders of ₹388 crore on revenue of ₹4,643 crore, against ₹1,942 crore on ₹25,229 crore for Apollo Hospitals Enterprise. Aster DM Healthcare's operating margin was 13.7% (Apollo Hospitals Enterprise 11.5%) and its return on equity 9.7% (Apollo Hospitals Enterprise 22.0%). At the 29 October 2026 close, Aster DM Healthcare's market capitalisation was ₹35,191 crore against ₹1,17,916 crore for Apollo Hospitals Enterprise, and its PE ratio on FY26 profit 90.7 against 60.7.

What is the Aster DM Healthcare revenue and profit in FY26?

In FY26 (April 2025–March 2026), Aster DM Healthcare's consolidated net profit attributable to shareholders was ₹388 crore, down 92.8% from ₹5,378 crore in FY25, on revenue from operations of ₹4,643 crore (up 12.2%). Over three years, from FY23, net profit was down 8.7%.

How does Aster DM Healthcare compare with its peers?

On FY26 consolidated figures, against Apollo Hospitals Enterprise, Max Healthcare Institute and Krishna Institute of Medical Sciences: Aster DM Healthcare's operating margin of 13.7% is the second highest of the four (Apollo Hospitals Enterprise 11.5%, Max Healthcare Institute 21.5%, Krishna Institute of Medical Sciences 13.3%; peer average 15.4%); its return on equity of 9.7% is the lowest of the four (Apollo Hospitals Enterprise 22.0%, Max Healthcare Institute 14.3%, Krishna Institute of Medical Sciences 11.0%; peer average 15.8%); its revenue growth over three years of −27.0% a year is the lowest of the four (Apollo Hospitals Enterprise 14.9% a year, Max Healthcare Institute 22.4% a year, Krishna Institute of Medical Sciences 21.1% a year; peer average 19.5% a year).

Where do these Aster DM Healthcare figures come from?

From Aster DM Healthcare's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.